Sentien Biotechnologies, Inc. awarded NIH Phase I SBIR Award for Kidney Program
Filter: PRESS RELEASES IN THE NEWS EVENTS
Sentien Biotechnologies, Inc. awarded NIH Phase I SBIR Award for Kidney Program
This Phase I SBIR grant advances pre-clinical work to scale up Sentien’s technology for human use.